Emerging Role of EGFR-Targeted Therapy in Resectable Lung Cancer

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the WayПодробнее

Emerging role of ADCs in EGFR-mutated non-small cell lung cancerПодробнее

Maximizing the Impact of EGFR-Targeted Therapy in Resectable NSCLCПодробнее

Drs. Sepesi & Cascone discuss EGFR-targeted therapy in early-stage NSCLC: https://bit.ly/3oZllfoПодробнее

Neoadjuvant Osimertinib and Surgically Resectable EGFR+ - Targeted Therapies in Lung Cancer 2023Подробнее

Dr. Villaruz on EGFR-Targeted Therapies in NSCLCПодробнее

Targeted treatment with EGFR TKIs: Front line optionsПодробнее

Dr. Shum on Emerging Targeted Therapies in EGFR-Mutant NSCLCПодробнее

Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative SettingsПодробнее

Emerging Molecular Targets For Advanced Non Small Cell Lung Cancer NSCLCПодробнее

EGFR Positive WebinarПодробнее

Next-Generation Targeted Therapies in Non-Small Cell Lung CancerПодробнее

GRACE Targeted Therapies Lung Cancer 2021 - Current Treatment Options for EGFR Fusions e.g. RAD 51Подробнее

Clinical trials of neoadjuvant targeted therapy in resectable NSCLCПодробнее

Emerging role of adjuvant immunotherapy in oncologyПодробнее

Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLCПодробнее

Lung Cancer Video Library 2020 - PATEL Emerging Molecular Targets in NSCLC EGFR Exon 20Подробнее

GRACE Targeted Therapies Lung Cancer 2021 - Will There Ever Be Opportunity to Use TKI + IO Together?Подробнее

Dr. West on Emerging Changes in the Field of EGFR-Mutant NSCLCПодробнее